Am Heart J
- LURIE A, Daneii P, Sze CH, Khanani A, et al
Design and rationale of the Urine Sodium-directed Diuretic Adjustment Strategy in
Heart Failure (US-DASH) trial.
Am Heart J. 2026 Oct 6:107622. doi: 10.1016/j.ahj.2026.107622.
Am J Cardiol
- QURESHI S, Sajid M, Khan HR, Greene SJ, et al
Association between Socioeconomic Deprivation and Clinical Outcomes of
Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure.
Am J Cardiol. 2026 Oct 9:S0002-9149(26)00619.
Chest
- MOLINGER J, Fudim M
The Respiratory Muscles in Heart Failure With Preserved Ejection Fraction: A
Hidden Tax on Exercise Tolerance.
Chest. 2026;170:998-1000.
- SULICA R, De Marco T, Elwing JM, Bartolome S, et al
Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.
Chest. 2026;170:1260-1271.
Circ Arrhythm Electrophysiol
- AFZALIAN A, Oraii A, Chaumont C, Rodriguez-Queralto O, et al
Value of Left Ventricular Low Voltage Area and Ejection Fraction in Predicting
End-Stage Heart Failure Outcomes After Ventricular Tachycardia Ablation in
Patients With Non-Ischemic Cardiomyopathy.
Circ Arrhythm Electrophysiol. 2026 Oct 8:e014886. doi: 10.1161/CIRCEP.126.014886
Circulation
- KOMURO J, Ko T, Ito M, Hashimoto H, et al
Mast Cell-Derived IL-4 Induces Pathogenic Cardiac Fibroblasts in Heart Failure.
Circulation. 2026;154:1378-1381.
Clin Cardiol
- AVERBUCH T, Miller RJH, Ezekowitz J, Howlett JG, et al
Prognostic Significance and Factors Associated With Worsening LV Dilatation in
Heart Failure.
Clin Cardiol. 2026;49:e70490.
- KHAN A, Shabbir MR, Nasrallah J, Imtiaz M, et al
Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart
Failure: A Propensity-Matched Analysis.
Clin Cardiol. 2026;49:e70488.
Eur Heart J
- LAOUTARIS ID, Dritsas A, Adamopoulos S
Training the diaphragm as a pillar of cardiac rehabilitation in heart failure.
Eur Heart J. 2026 Oct 5:ehag789. doi: 10.1093.
- ELBATREEK MH, Li Z, Yu X, Gehred ND, et al
Semaglutide, independent of weight loss, attenuates cardiac and hepatic
remodelling in experimental heart failure with preserved ejection fraction.
Eur Heart J. 2026 Oct 5:ehag732. doi: 10.1093.
- ZIZEK D, Ivanovski M, Mrak M, Pestrea C, et al
Biventricular vs conduction system pacing after atrioventricular node ablation
for heart failure with atrial fibrillation: the CONDUCT-AF trial.
Eur Heart J. 2026 Oct 6:ehag699. doi: 10.1093.
- YALCIN GD, Meder B
The power of proteomics: predicting mortality in heart failure.
Eur Heart J. 2026 Oct 8:ehag721. doi: 10.1093.
Eur J Heart Fail
- KOBAYASHI M, Duarte K, Baudry G, Ferreira JP, et al
Kidney function decline, heart failure hospitalization, and the effect of
empagliflozin in heart failure: an EMPEROR-pooled analysis.
Eur J Heart Fail. 2026 Oct 6:xuag295. doi: 10.1093.
- TORRELLES A, Domingo M, Zamora E, Lupon J, et al
SAFE-EXIT HF Study: Integrating Ultrasound Congestion Assessment with Clinical
Variables to Predict Outcomes After Heart Failure Hospitalization.
Eur J Heart Fail. 2026 Oct 6:xuag300. doi: 10.1093.
- BAUDRY G
Revisiting dry weight in heart failure: a treatment-defined target in the era of
foundational medical therapy?
Eur J Heart Fail. 2026 Oct 6:xuag304. doi: 10.1093.
-
Correction to: Implementation of guideline-directed medical therapy in patients
with heart failure and obesity: European Journal of Heart Failure expert
consensus document.
Eur J Heart Fail. 2026 Oct 8:xuag264. doi: 10.1093.
- BIEGUS J, Davison B, Cotter G, Edwards C, et al
GDMT is Associated with Reduced Loop Diuretic Requirements, Whereas Diuretic Dose
Does Not Modify GDMT Benefit in Heart Failure: STRONG-HF.
Eur J Heart Fail. 2026 Oct 9:xuag309. doi: 10.1093.
Heart
- CHRISTENSEN MK, Pedersen AK, Hyldgard VB, Moller JE, et al
Timing of heart failure diagnosis and uptake of newly recommended therapies
following clinical guideline updates.
Heart. 2026 Oct 8:heartjnl-2025-327578. doi: 10.1136/heartjnl-2025-327578.
Int J Cardiol
- CASTIGLIONE V, Aimo A, Vergaro G
High-sensitivity troponin T to suspect transthyretin amyloidosis in acute heart
failure: is hospital admission the right time?
Int J Cardiol. 2026 Oct 8:134976. doi: 10.1016/j.ijcard.2026.134976.
J Am Coll Cardiol
- LALANI C, Butala N, Dong H, Song Y, et al
Estimating the Effects of MTEER in U.S. Practice: A Transportability Analysis of
the COAPT Trial.
J Am Coll Cardiol. 2026;88:1704-1716.
J Card Fail
- PACKER M, Butler J, Zannad F, Vaduganathan M, et al
The Comorbidity-Driven Interleukin-6-Mediated Systemic Inflammation Hypothesis of
Heart Failure With Preserved Ejection Fraction: A Decade of Testing Ends in
Disappointment.
J Card Fail. 2026 Oct 5:S1071-9164(26)00594.
- GORODESKI EZ, Fonarow GC, Goyal P, Ahmad FS, et al
HF STATS 2026: An Updated Report on Heart Failure Epidemiology and Outcomes from
the Heart Failure Society of America.
J Card Fail. 2026 Oct 5:S1071-9164(26)00406.
J Cardiol
- KUBOTA Y, Tanaka H, Fujimoto W, Yokota H, et al
Impact of dementia and its progression on mortality in heart failure with
preserved ejection fraction -insight from the KUNIUMI registry chronic cohort.
J Cardiol. 2026 Oct 7:S0914-5087(26)00192-9. doi: 10.1016/j.jjcc.2026.
J Mol Cell Cardiol
- IQBAL Z, Fiegle D, Minabari G, Heim C, et al
A transmural t-tubule gradient in the human left ventricle is lost in heart
failure: implications for myocardial biopsy assessment.
J Mol Cell Cardiol. 2026 Oct 9:S0022-2828(26)00158.
PLoS One
- GOWANI A, Norris C, Low G, Ajani K, et al
Translation and cultural adaptation of the Minnesota Living with Heart Failure
Questionnaire for use in Pakistan.
PLoS One. 2026;21:e0360245.
- HAKANSSON E, Anan I, Brunstrom M, Hellstrom-Angerud K, et al
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An
n-of-1 trial series pilot study.
PLoS One. 2026;21:e0346065.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016